(LifeSiteNews) — Acting Food and Drug Administration (FDA) commissioner Kyle Diamantas has promised he will be the “most pro-life FDA commissioner that the FDA has ever had.”  

Diamantas made his promise to Students for Life president Kristan Hawkins, according to The Daily Signal. 

Shortly after his appointment as acting FDA head, Diamantas reached out to pro-life leaders, including Hawkins, Live Action president Lila Rose, and March for Life president Jennie Lichter. 

Diamantas was responding to concerns about his past legal work on behalf of Planned Parenthood, insisting he is pro-life and that he sought to be removed from the pro-abortion assignment. 

On Tuesday, the White House confirmed the resignation of FDA chief Marty Makary amid a storm of issues, including internal staff turmoil and his handling of abortion pills, vaccines, and nicotine products.

READ: March for Life confirms acting FDA leader regretted Planned Parenthood work

On Wednesday, Lila Rose revealed she had spoken with Diamantas, who sought to answer pro-life fears.

“He told me he regrets work he performed as an outside attorney for Planned Parenthood in Planned Parenthood of Greater Orlando v. MMB Properties,” Rose said. “He shared that he was assigned to the case by his law firm, performed work on it, and ultimately regretted his involvement because of his moral opposition to abortion. He then asked his superiors to remove him from the case. He said that he is pro-life and cares deeply about the pro-life cause.”

“I also raised the urgent crisis of the abortion pill,” she added. “Nearly 11% of women who take mifepristone experience serious adverse events, and the abortion pill has killed millions of American babies. Diamantas told me that reviewing the abortion pill is a top priority for him and the administration.”

Today I spoke directly with Acting FDA Commissioner Kyle Diamantas.

He told me he regrets work he performed as an outside attorney for Planned Parenthood in Planned Parenthood of Greater Orlando v. MMB Properties. He shared that he was assigned to the case by his law firm,…

— Lila Rose (@LilaGraceRose) May 13, 2026

March for Life president Jennie Lichter said she too is now optimistic about Diamantas taking the helm at the FDA. 

“Had a great convo last night with Kyle Diamantas, the new acting FDA Commissioner. In other words, within hours of being handed this big new job, he was on the phone with pro-life leaders – which is an encouraging sign of where his priorities lie,” she wrote on X on May 13.

“I’m optimistic that the cause of life will get a full and fair hearing at the FDA, incl. real movement on the mifepristone safety study,” Lichter stated.

The March for Life is “looking forward to working with” the FDA “in this new era to make sure abortion drug companies can’t continue to lie to women about their drugs that are NOT ‘safer than tylenol,’” Lichter wrote.

Had a great convo last night with Kyle Diamantas, the new acting FDA Commissioner. In other words, within hours of being handed this big new job, he was on the phone with pro-life leaders – which is an encouraging sign of where his priorities lie.

After talking w him I’m…

— Jennie Bradley Lichter (@JennieMFL) May 13, 2026

While Diamantas’ recent comments are encouraging, Rose stressed, “Now we need to see action. The FDA must urgently take action on mifepristone, confront the mounting evidence of harm to women, and address the abortion pill regime that has killed millions of preborn children. We and millions of Americans across the nation who value the right to life expect this administration to advance strong pro-life protections for both mothers and their children.”